Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
Janssen QP, van Dam JL, Prakash LR, Doppenberg D, Crane CH, van Eijck CHJ, Ellsworth SG, Jarnagin WR, O'Reilly EM, Paniccia A, Reyngold M, Besselink MG, Katz MHG, Tzeng CD, Zureikat AH, Groot Koerkamp B, Wei AC; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Janssen QP, et al. Among authors: doppenberg d. J Natl Compr Canc Netw. 2022 Jul;20(7):783-791.e1. doi: 10.6004/jnccn.2022.7008. J Natl Compr Canc Netw. 2022. PMID: 35830887 Free PMC article.
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium.
Janssen QP, van Dam JL, Doppenberg D, Prakash LR, van Eijck CHJ, Jarnagin WR, O' Reilly EM, Paniccia A, Besselink MG, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Janssen QP, et al. Among authors: doppenberg d. J Natl Cancer Inst. 2022 May 9;114(5):695-703. doi: 10.1093/jnci/djac018. J Natl Cancer Inst. 2022. PMID: 35157075 Free PMC article.
Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
Theijse RT, Stoop TF, Janssen QP, Prakash LR, Katz MHG, Doppenberg D, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG. Theijse RT, et al. Among authors: doppenberg d. Br J Surg. 2024 Mar 2;111(3):znae033. doi: 10.1093/bjs/znae033. Br J Surg. 2024. PMID: 38456678 Free PMC article.
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Dekker EN, et al. Among authors: doppenberg d. J Clin Oncol. 2024 Apr 20;42(12):1357-1367. doi: 10.1200/JCO.23.01311. Epub 2024 Feb 5. J Clin Oncol. 2024. PMID: 38315954
ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9.
Stoop TF, Doppenberg D, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Stoop TF, et al. Among authors: doppenberg d. Ann Surg Oncol. 2024 Mar;31(3):1842-1843. doi: 10.1245/s10434-023-14815-3. Epub 2024 Jan 5. Ann Surg Oncol. 2024. PMID: 38182848 Free PMC article. No abstract available.
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N, Prakash LR, Theijse RT, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Doppenberg D, et al. Ann Surg Oncol. 2024 Mar;31(3):1919-1932. doi: 10.1245/s10434-023-14680-0. Epub 2024 Jan 3. Ann Surg Oncol. 2024. PMID: 38170408
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.
Zwart ES, van Ee T, Doppenberg D, Farina A, Wilmink JW, Versteijne E, Busch OR, Besselink MG, Meijer LL, van Kooyk Y, Mebius RE, Kazemier G. Zwart ES, et al. Among authors: doppenberg d. J Cancer Res Clin Oncol. 2023 Nov;149(16):14731-14743. doi: 10.1007/s00432-023-05219-7. Epub 2023 Aug 17. J Cancer Res Clin Oncol. 2023. PMID: 37587309 Free PMC article.
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study.
Seelen LWF, Doppenberg D, Stoop TF, Nagelhout A, Brada LJH, Bosscha K, Busch OR, Cirkel GA, den Dulk M, Daams F, van Dieren S, van Eijck CHJ, Festen S, Groot Koerkamp B, Haj Mohammad N, de Hingh IHJT, Lips DJ, Los M, de Meijer VE, Patijn GA, Polée MB, Stommel MWJ, Walma MS, de Wilde RF, Wilmink JW, Molenaar IQ, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Seelen LWF, et al. Among authors: doppenberg d. Ann Surg. 2024 May 1;279(5):832-841. doi: 10.1097/SLA.0000000000006021. Epub 2023 Jul 21. Ann Surg. 2024. PMID: 37477009
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
Doppenberg D, van Dam JL, Han Y, Bonsing BA, Busch OR, Festen S, van der Harst E, de Hingh IH, Homs MYV, Kwon W, Lee M, Lips DJ, de Meijer VE, Molenaar IQ, Nuyttens JJ, Patijn GA, van Roessel S, van der Schelling GP, Suker M, Versteijne E, de Vos-Geelen J, Wilmink JW, van Eijck CHJ, van Tienhoven G, Jang JY, Besselink MG, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Doppenberg D, et al. Br J Surg. 2023 Sep 6;110(10):1374-1380. doi: 10.1093/bjs/znad210. Br J Surg. 2023. PMID: 37440421 Free PMC article.
Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.
Doppenberg D, Lagerwaard FJ, van Dieren S, Meijerink MR, van der Vliet JJ, Besselink MG, van Tienhoven G, Versteijne E, Slotman BJ, Wilmink JW, Kazemier G, Bruynzeel AME. Doppenberg D, et al. Front Oncol. 2023 May 31;13:1149961. doi: 10.3389/fonc.2023.1149961. eCollection 2023. Front Oncol. 2023. PMID: 37324027 Free PMC article.
13 results